120 related articles for article (PubMed ID: 24873349)
1. Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells.
Rakovich TY; Mahfoud OK; Mohamed BM; Prina-Mello A; Crosbie-Staunton K; Van Den Broeck T; De Kimpe L; Sukhanova A; Baty D; Rakovich A; Maier SA; Alves F; Nauwelaers F; Nabiev I; Chames P; Volkov Y
ACS Nano; 2014 Jun; 8(6):5682-95. PubMed ID: 24873349
[TBL] [Abstract][Full Text] [Related]
2. Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Ramos-Gomes F; Bode J; Sukhanova A; Bozrova SV; Saccomano M; Mitkovski M; Krueger JE; Wege AK; Stuehmer W; Samokhvalov PS; Baty D; Chames P; Nabiev I; Alves F
Sci Rep; 2018 Mar; 8(1):4595. PubMed ID: 29545609
[TBL] [Abstract][Full Text] [Related]
3. Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging.
Gonda K; Miyashita M; Higuchi H; Tada H; Watanabe TM; Watanabe M; Ishida T; Ohuchi N
Sci Rep; 2015 Sep; 5():14322. PubMed ID: 26392299
[TBL] [Abstract][Full Text] [Related]
4. Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates.
Rousserie G; Grinevich R; Brazhnik K; Even-Desrumeaux K; Reveil B; Tabary T; Chames P; Baty D; Cohen JH; Nabiev I; Sukhanova A
Anal Biochem; 2015 Jun; 478():26-32. PubMed ID: 25766579
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared quantum dots for HER2 localization and imaging of cancer cells.
Rizvi SB; Rouhi S; Taniguchi S; Yang SY; Green M; Keshtgar M; Seifalian AM
Int J Nanomedicine; 2014; 9():1323-37. PubMed ID: 24648731
[TBL] [Abstract][Full Text] [Related]
6. Accurate sensitivity of quantum dots for detection of HER2 expression in breast cancer cells and tissues.
Tabatabaei-Panah AS; Jeddi-Tehrani M; Ghods R; Akhondi MM; Mojtabavi N; Mahmoudi AR; Mirzadegan E; Shojaeian S; Zarnani AH
J Fluoresc; 2013 Mar; 23(2):293-302. PubMed ID: 23212129
[TBL] [Abstract][Full Text] [Related]
7. Detection of melanoma using antibody-conjugated quantum dots in a coculture model for high-throughput screening system.
Kim MJ; Lee JY; Nehrbass U; Song R; Choi Y
Analyst; 2012 Mar; 137(6):1440-5. PubMed ID: 22310726
[TBL] [Abstract][Full Text] [Related]
8. Characterization and cancer cell specific binding properties of anti-EGFR antibody conjugated quantum dots.
Lee J; Choi Y; Kim K; Hong S; Park HY; Lee T; Cheon GJ; Song R
Bioconjug Chem; 2010 May; 21(5):940-6. PubMed ID: 20420360
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore.
Zhang H; Zeng X; Li Q; Gaillard-Kelly M; Wagner CR; Yee D
Br J Cancer; 2009 Jul; 101(1):71-9. PubMed ID: 19491901
[TBL] [Abstract][Full Text] [Related]
10. Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells.
Jung Y; Park HJ; Kim PH; Lee J; Hyung W; Yang J; Ko H; Sohn JH; Kim JH; Huh YM; Yun CO; Haam S
J Control Release; 2007 Nov; 123(2):164-71. PubMed ID: 17854941
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
[TBL] [Abstract][Full Text] [Related]
12. Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.
Even-Desrumeaux K; Fourquet P; Secq V; Baty D; Chames P
Mol Biosyst; 2012 Sep; 8(9):2385-94. PubMed ID: 22772166
[TBL] [Abstract][Full Text] [Related]
13. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer.
Chen C; Peng J; Xia HS; Yang GF; Wu QS; Chen LD; Zeng LB; Zhang ZL; Pang DW; Li Y
Biomaterials; 2009 May; 30(15):2912-8. PubMed ID: 19251316
[TBL] [Abstract][Full Text] [Related]
14. HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas.
Ricardo SA; Milanezi F; Carvalho ST; Leitão DR; Schmitt FC
J Clin Pathol; 2007 Sep; 60(9):1001-5. PubMed ID: 17158643
[TBL] [Abstract][Full Text] [Related]
15. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots.
Wu X; Liu H; Liu J; Haley KN; Treadway JA; Larson JP; Ge N; Peale F; Bruchez MP
Nat Biotechnol; 2003 Jan; 21(1):41-6. PubMed ID: 12459735
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection with quantum dots.
Akhtar RS; Latham CB; Siniscalco D; Fuccio C; Roth KA
Methods Mol Biol; 2007; 374():11-28. PubMed ID: 17237526
[TBL] [Abstract][Full Text] [Related]
17. Mortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interaction.
Pietilä M; Lehenkari P; Kuvaja P; Kaakinen M; Kaul SC; Wadhwa R; Uemura T
Exp Cell Res; 2013 Nov; 319(18):2770-80. PubMed ID: 23928292
[TBL] [Abstract][Full Text] [Related]
18. Her2-positive breast cancer: herceptin and beyond.
Dean-Colomb W; Esteva FJ
Eur J Cancer; 2008 Dec; 44(18):2806-12. PubMed ID: 19022660
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer.
Lottner C; Schwarz S; Diermeier S; Hartmann A; Knuechel R; Hofstaedter F; Brockhoff G
J Pathol; 2005 Apr; 205(5):577-84. PubMed ID: 15732132
[TBL] [Abstract][Full Text] [Related]
20. A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor - Quantum dot conjugates and a panel of chromogenic dyes.
Sharaf SS; Lekshmi A; S A; K G A; Jyothi S P A; Chandrasekharan A; Somanathan T; Santhosh Kumar TR; K S
Pathol Res Pract; 2024 Jan; 253():155033. PubMed ID: 38134837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
